Novo-Nordisk stock ends the day 1.0 percent lower at USD 39.40
Published on 09/22/2026 at 23:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Novo-Nordisk stock ended the regular session at USD 39.40 on the NYSE on September 22, 2026, down 1.0 percent from the prior close. The shares traded between USD 39.10 and USD 39.89 during the session, a USD 0.49 range.
September 22, 2026 in numbers
Novo-Nordisk A/S (ISIN DK0062498333) opened at USD 39.80 and finished USD 0.49 below the session high. Trading volume reached 23.9 million shares, compared with an average volume of 12.1 million shares, according to the session data reported by The Motley Fool. The stock therefore traded at 1.98 times that average.
The U.S.-listed shares lagged the broader market: the S&P 500 closed at 7,764.64, down 0.06 percent on September 22, 2026, while Novo-Nordisk stock fell 1.0 percent. The session followed the company capital markets event, where management presented mid-single-digit revenue growth targets through 2030 and broadly stable adjusted operating margins, as reported by TradingView.
After the bell today
Novo Nordisk's capital markets event also highlighted plans for more than five potential blockbuster medicines by 2030. CNBC reported that the company expects those products to generate more than 150 billion Danish kroner in sales by 2035.
